User profiles for Viveka Nand Yadav
 | Vivekanand Yadav PhDAssistant Professor, Department of Pediatric at Children's Mercy Research Institute Verified email at cmh.edu Cited by 1221 |
Targeting and therapeutic monitoring of H3K27M-mutant glioma
…, R Ravindran, R Teodoro, VN Yadav… - Current oncology …, 2020 - Springer
… Vivek Yadav declares that he has no conflict of interest. … The original version of this article
was revised: Author Viveka Nand Yadav’s name was inadvertently captured as “Vivek Yadav”. …
was revised: Author Viveka Nand Yadav’s name was inadvertently captured as “Vivek Yadav”. …
[HTML][HTML] Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and …
As glioma cells infiltrate the brain they become associated with various microanatomic brain
structures such as blood vessels, white matter tracts, and brain parenchyma. How these …
structures such as blood vessels, white matter tracts, and brain parenchyma. How these …
[PDF][PDF] Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas
…, DR Wahl, CA Lyssiotis, Z Bian, JB Shotwell, VN Yadav… - Cancer cell, 2020 - cell.com
H3K27M diffuse intrinsic pontine gliomas (DIPGs) are fatal and lack treatments. They mainly
harbor H3.3K27M mutations resulting in H3K27me3 reduction. Integrated analysis in H3.…
harbor H3.3K27M mutations resulting in H3K27me3 reduction. Integrated analysis in H3.…
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
…, K Ravi, C Thomas, R Cartaxo, V Nand Yadav… - Neuro …, 2022 - academic.oup.com
Background Diffuse Midline Glioma (DMG) with the H3K27M mutation is a lethal childhood
brain cancer, with patients rarely surviving 2 years from diagnosis. Methods We conducted a …
brain cancer, with patients rarely surviving 2 years from diagnosis. Methods We conducted a …
[PDF][PDF] ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization
ATRX, a chromatin remodeler protein, is recurrently mutated in H3F3A-mutant pediatric
glioblastoma (GBM) and isocitrate dehydrogenase (IDH)-mutant grade 2/3 adult glioma. …
glioblastoma (GBM) and isocitrate dehydrogenase (IDH)-mutant grade 2/3 adult glioma. …
[PDF][PDF] TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
…, E Guruceaga, C Koschmann, VN Yadav… - Cancer cell, 2023 - cell.com
Diffuse intrinsic pontine glioma (DIPG) is an aggressive brain stem tumor and the leading
cause of pediatric cancer-related death. To date, these tumors remain incurable, underscoring …
cause of pediatric cancer-related death. To date, these tumors remain incurable, underscoring …
[HTML][HTML] CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study
Glioblastoma (GBM) is a highly invasive brain tumor. Perivascular invasion, autovascularization
and vascular co-option occur throughout the disease and lead to tumor invasion and …
and vascular co-option occur throughout the disease and lead to tumor invasion and …
[HTML][HTML] Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
…, S Kong, E Cantor, C Koschmann, VN Yadav - Frontiers in …, 2022 - frontiersin.org
Pediatric high-grade glioma (pHGG), including both diffuse midline glioma (DMG) and non-midline
tumors, continues to be one of the deadliest oncologic diagnoses (both henceforth …
tumors, continues to be one of the deadliest oncologic diagnoses (both henceforth …
Natural killer cells eradicate galectin-1–deficient glioma in the absence of adaptive immunity
Natural killer (NK) cells safeguard against early tumor formation by destroying transformed
target cells in a process referred to as NK immune surveillance. However, the immune …
target cells in a process referred to as NK immune surveillance. However, the immune …
Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
Z Miklja, VN Yadav, RT Cartaxo… - The Journal of …, 2020 - Am Soc Clin Investig
Pediatric and adult high-grade gliomas (HGGs) frequently harbor PDGFRA alterations. We
hypothesized that cotreatment with everolimus may improve the efficacy of dasatinib in …
hypothesized that cotreatment with everolimus may improve the efficacy of dasatinib in …
